Evidence map›Paper›PMID 30586411›Full record

ArticlePLoS genetics2018

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.

Melissa S Cline, Rachel G Liao, Michael T Parsons, Benedict Paten, Faisal Alquaddoomi, Antonis Antoniou, Samantha Baxter, Larry Brody, Robert Cook-Deegan, Amy Coffin and 37 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 2 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 2 syntheses or guidelines pooled it, 207 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cancer genomic profiling predicts pathogenicity ofmedRxiv : the preprint server for health sciences · 2026
    Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

47 authors at 20 institutions in 8 countries.

Melissa S ClineUniversity of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
Rachel G LiaoBroad Institute, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-7830-1976
Michael T ParsonsGenetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0003-3242-8477
Benedict PatenDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Faisal AlquaddoomiDepartment of Computer Science, Biomedical Informatics Group Universitätsstrasse, Zürich, Switzerland.ORCID 0000-0003-4297-8747
Antonis AntoniouCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Samantha BaxterDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.ORCID 0000-0003-4616-9234
Larry BrodyMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, United States of America.
Robert Cook-DeeganSchool for the Future of Innovation in Society, and Consortium for Science, Policy & Outcomes, Arizona State University, Tempe, Arizona, United States of America.
Amy CoffinUniversity of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.ORCID 0000-0003-2723-8222
Fergus J CouchDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Brian CraftUniversity of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
Robert CurrieUniversity of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.ORCID 0000-0003-1828-1827
Chloe C DlottUniversity of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.ORCID 0000-0002-7268-7230
Lena DolmanThe Global Alliance for Genomics and Health, Toronto, Ontario, Canada.ORCID 0000-0002-3938-588X
Johan T den DunnenDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Stephanie O M DykeCentre of Genomics and Policy, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Susan M DomchekPerelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Douglas EastonCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Zachary FischmannUniversity of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.ORCID 0000-0002-7687-0972
William D FoulkesProgram in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montréal, Quebec, Canada.ORCID 0000-0001-7427-4651
Judy GarberDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
David GoldgarHuntsman Cancer Institute and Department of Dermatology, University of Utah, Salt Lake City, Utah, United States of America.
Mary J GoldmanUniversity of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.ORCID 0000-0002-9808-6388
Peter GoodhandThe Global Alliance for Genomics and Health, Toronto, Ontario, Canada.ORCID 0000-0002-2624-2820
Steven HarrisonPartners HealthCare Laboratory for Molecular Medicine and Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-9614-9111
David HausslerUniversity of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.ORCID 0000-0003-1533-4575
Kazuto KatoGraduate School of Medicine, Osaka University, Osaka, Japan.
Bartha KnoppersCentre of Genomics and Policy, Faculty of Medicine, Human Genetics, McGill University, Montreal, Québec, Canada.
Charles MarkelloUniversity of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.ORCID 0000-0002-3653-7155
Robert NussbaumInvitae, San Francisco, California, United States of America.
Kenneth OffitClinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Sharon E PlonDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America.ORCID 0000-0002-9626-0936
Jem RashbassNational Disease Registration, National Cancer Registration and Analysis Service, Public Health England, London, United Kingdom.
Heidi L RehmLaboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-6025-0015
Mark RobsonClinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Wendy S RubinsteinCancerLinQ at American Society of Clinical Oncology (ASCO), Alexandria, Virginia, United States of America.ORCID 0000-0002-8790-9959
Dominique Stoppa-LyonnetInstitut Curie, Cancer Genetic Clinic, Paris, France.
Sean TavtigianPartners HealthCare Laboratory for Molecular Medicine and Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-7543-8221
Adrian ThorogoodThe Global Alliance for Genomics and Health, Toronto, Ontario, Canada.ORCID 0000-0001-5078-8164
Can ZhangDepartment of Computer Science, University of California, Santa Cruz, Santa Cruz, California, United States of America.
Marc ZimmermannDepartment of Computer Science, Biomedical Informatics Group Universitätsstrasse, Zürich, Switzerland.
BRCA Challenge Authors
John BurnInstitute of Genetic Medicine, Newcastle University, Centre for Life, Newcastle upon Tyne, United Kingdom.
Stephen ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.ORCID 0000-0002-2324-3393
Gunnar RätschDepartment of Computer Science, Biomedical Informatics Group Universitätsstrasse, Zürich, Switzerland.ORCID 0000-0001-5486-8532
Amanda B SpurdleGenetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Australia.ORCID 0000-0003-1337-7897
University of California, Santa Cruz · USHarvard University · USOntario Genomics · CACentre for Life · GBMcGill University · CAMemorial Sloan Kettering Cancer Center · USQIMR Berghofer Medical Research Institute · AUSIB Swiss Institute of Bioinformatics · CHUniversity of Cambridge · GBAmerican Society of Clinical Oncology · USBaylor College of Medicine · USBrigham and Women's Hospital · USBroad Institute · USInstitut Curie · FRInstitute for the Future · USInvitae (United States) · USLeiden University Medical Center · NLMayo Clinic in Florida · USMcGill Genome Centre · CANational Human Genome Research Institute · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Resource ProjectU41HG006834 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI REHM, HEIDI L · 2013 to 2020
$26.9M
Training SubprojectU54HG007990 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H, PATTERSON, DAVID · 2014 to 2018
$14.8M
The Future of PharmGKB Funding Under NHGRIU41HG009649 · NHGRI · STANFORD UNIVERSITY · PI BUSTAMANTE, CARLOS DANIEL · 2017 to 2020
$13.4M
Global Alliance for Genomic Health (GA4GH)U01HG008676 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI LENNON, NIALL JOHN, REHM, HEIDI L · 2015 to 2019
$8.6M
Global Infrastructure for Collaborative High-throughput Cancer Genomics AnalysisU24CA210999 · NCI · BROAD INSTITUTE, INC. · PI GETZ, GAD A · 2016 to 2020
$4.7M
Visualization hub for genomics data exploration and translational discoveryU24CA210974 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI COLLISSON, ERIC, HAUSSLER, DAVID H · 2016 to 2020
$4.2M
Cloud Based Resource for Data Hosting, Visualization and Analysis Using UCSC CancU24CA180951 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H · 2013 to 2017
$2.9M
Building the Medical Information Commons: Participant Engagement and PolicyR01HG008918 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI COOK-DEEGAN, ROBERT MULLAN, MCGUIRE, AMY L · 2015 to 2017
$2.4M
The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancerZIAHG000120 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BRODY, LAWRENCE C · 2009 to 2019
$980k
CIHRCIHR #141210NCI NIH HHS P30 CA008748NCI NIH HHS U24 CA180951NCI NIH HHS U24 CA210974NCI NIH HHS U24 CA210999NHGRI NIH HHS R01 HG008918NHGRI NIH HHS U01 HG008676NHGRI NIH HHS U41 HG006834NHGRI NIH HHS U41 HG009649NHGRI NIH HHS U54 HG007990
6 · The paper itself

Abstract

The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Genomics and Health (GA4GH) to aggregate BRCA1 and BRCA2 data to support highly collaborative research activities. Its goal is to generate an informed and current understanding of the impact of genetic variation on cancer risk across the iconic cancer predisposition genes, BRCA1 and BRCA2. Initially, reported variants in BRCA1 and BRCA2 available from public databases were integrated into a single, newly created site, www.brcaexchange.org. The purpose of the BRCA Exchange is to provide the community with a reliable and easily accessible record of variants interpreted for a high-penetrance phenotype. More than 20,000 variants have been aggregated, three times the number found in the next-largest public database at the project's outset, of which approximately 7,250 have expert classifications. The data set is based on shared information from existing clinical databases-Breast Cancer Information Core (BIC), ClinVar, and the Leiden Open Variation Database (LOVD)-as well as population databases, all linked to a single point of access. The BRCA Challenge has brought together the existing international Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) consortium expert panel, along with expert clinicians, diagnosticians, researchers, and database providers, all with a common goal of advancing our understanding of BRCA1 and BRCA2 variation. Ongoing work includes direct contact with national centers with access to BRCA1 and BRCA2 diagnostic data to encourage data sharing, development of methods suitable for extraction of genetic variation at the level of individual laboratory reports, and engagement with participant communities to enable a more comprehensive understanding of the clinical significance of genetic variation in BRCA1 and BRCA2.

Indexed as

Databases, GeneticGenes, BRCA1Genes, BRCA2Genetic VariationAllelesBreast NeoplasmsFemaleGene FrequencyGenetic Predisposition to DiseaseHumansInformation DisseminationMaleMutationOvarian NeoplasmsPenetrancePhenotype

Identifiers

PMID30586411
PMCPMC6324924
OpenAlexW2905840501

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.